Added 16,000 customers in Q4, 75,900 new customers in FY 2023 Reported Q4 revenue of $357 million; FY 2023 revenue of $1.7 billion Reported Q4 GAAP Net Loss of ($124) million and Adjusted EBITDA of ($68) million; FY 2023 GAAP Net Loss of ($247) million and Adjusted EBITDA of ($84) million…
Month: February 2024
Contrasts EsoCheck’s powerful cell collection capabilities to “cruder, decades-old” technologies during comments on patient access to medical technology innovation NEW YORK, Feb. 15, 2024 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) a commercial-stage,…
Martin to Drive Growth and Expansion for Youth Baseball Properties, Including Ripken Baseball®, Cooperstown All Star Village, and Baseball Factory™ BALTIMORE, Feb. 15, 2024 /PRNewswire/ — Wade Martin, an accomplished executive in the sports and lifestyle industries, has been named CEO of…
SANTA CLARA, Calif., Feb. 15, 2024 /PRNewswire/ — Achronix Semiconductor Corporation, a leader in high-performance field-programmable gate arrays (FPGAs) and embedded FPGA (eFPGA) IP, today announced that management will participate at the following upcoming conferences: Baird Vehicle…
Parent Confidence Index highlights the increasing importance of child care to working parents; 6 out of 10 parents confirm that finding child care is becoming more difficult LAKE OSWEGO, Ore., Feb. 15, 2024 /PRNewswire/ — The results of KinderCare Learning Companies’ fifth annual Parent…
Only 30% of Americans feel confident their energy will remain affordable. Most US consumers believe they are doing everything they can to be sustainable (68%) and believe utilities should take the lead in shifting to cleaner energy (65%). Seventy percent of energy transition outcomes will…
REHOVOT, Israel, Feb. 15, 2024 /PRNewswire/ — Nova (Nasdaq: NVMI) today announced financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Highlights: Quarterly revenue of $134.2 million, up 4% QoQ, exceeding the high end of the guidance of $132…
Palatin’s Focus is Solely on the Development of its Melanocortin Receptor (MCR) System Pipeline PL9643 MELODY-1 Pivotal Phase 3 Study in Dry Eye Disease (DED) – Topline Data Expected in February Oral PL8177 Phase 2 Clinical Study in Patients with Ulcerative Colitis – Interim Analysis…
AUSTIN, Texas , Feb. 15, 2024 /PRNewswire/ — UNPRESS, a brand-new platform dedicated to authentic journalism and storytelling, launches with a mission to amplify the voices of next generation journalists and content creators who are reshaping the news and cultural landscape. Spearheaded…
The May 9th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases. COLUMBIA, Md., Feb. 15, 2024 /PRNewswire/ — The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases,…